Dose Derivation of Once-Daily Dosing Guidelines for Gentamicin in Critically Ill Pediatric Patients

被引:9
|
作者
Zakova, Maria [1 ]
Pong, Sandra [2 ]
Trope, Angela [2 ]
Atenafu, Eshetu G. [3 ]
Papaioannou, Vicky [4 ]
Bitnun, Sean Ari [5 ]
Richardson, Susan [6 ]
Schwartz, Steven [7 ]
Cox, Peter [7 ]
Parshuram, Christopher [7 ,8 ]
Seto, Winnie [2 ,8 ]
机构
[1] Hosp Sick Children, Dept Pharm, Div Hematol & Oncol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Dept Pharm, Crit Care Unit, Toronto, ON M5G 1X8, Canada
[3] Univ Hlth Network, Biostat Dept, Princess Margaret Canc Program, Toronto, ON, Canada
[4] Hosp Sick Children, Dept Commun Disorders, Toronto, ON M5G 1X8, Canada
[5] Hosp Sick Children, Div Infect Dis, Dept Infect Dis, Toronto, ON M5G 1X8, Canada
[6] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada
[7] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada
[8] Hosp Sick Children, Dept Crit Care Med, Child Hlth Evaluat Serv, Toronto, ON M5G 1X8, Canada
关键词
aminoglycosides; gentamicin; pediatric; critically ill; intensive care; INTENSIVE-CARE; METAANALYSIS; AMINOGLYCOSIDES; CHILDREN; PHARMACOKINETICS; THERAPY; PARAMETERS; TOBRAMYCIN; AMIKACIN; EFFICACY;
D O I
10.1097/FTD.0000000000000016
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives:To determine dose and eligibility criteria for once-daily dosing (ODD) of gentamicin in critically ill pediatric patients.Methods:Retrospective chart review of patients admitted to the Pediatric Intensive Care Unit or Cardiac Critical Care Unit at The Hospital for Sick Children (SickKids) who received traditionally dosed intravenous (IV) gentamicin (January 2008 to June 2010). Statistically significant patient characteristics associated with gentamicin pharmacokinetic (PK) parameters were determined by multiple linear regression. Binary partitioning was used to set critical values for these characteristics to derive dose for ODD of gentamicin. Feasibility of implementing ODD of gentamicin in critically ill children was assessed using individualized PK parameters to simulate area under the concentration-time curves and drug-free intervals while targeting a maximum concentration (C-max) of 16-20 mg/L. Eligibility criteria were determined by patient characteristics that had a statistically significant impact on gentamicin PK.Results:Volume of distribution (V-d) and elimination rate constant (k(e)) were calculated for 140 patients. Weight and admission unit were significantly associated with weight-normalized V-d (Vd/kg), whereas age and serum creatinine (SCr) were significantly associated with k(e). Weight <5 kg and SCr 20% over age-specific upper normal limit before gentamicin initiation were associated with prolonged gentamicin elimination. Gentamicin 6 mg/kg IV every 24 hours, the dose at which the highest percentage of patients achieved C-max, area under the curve, and drug-free interval within target ranges simultaneously, was selected as the proposed ODD regimen.Conclusions:A regimen of gentamicin 6 mg/kg IV every 24 hours for Pediatric Intensive Care Unit/Cardiac Critical Care Unit patients at SickKids weighing 5 kg with SCr <20% above age-specific upper normal limit before initiation of gentamicin is proposed.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [1] Pharmacokinetics of once-daily gentamicin dosing in pediatric patients - Discussion
    Scorpio, R
    Bass, KD
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (07) : 1107 - 1107
  • [2] Comment: once-daily aminoglycoside dosing in critically ill patients
    Wolfe, TA
    Dasta, JF
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (10) : 1109 - 1110
  • [3] The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
    Joynt, GM
    Lipman, J
    Gomersall, CD
    Young, RJ
    Wong, ELY
    Gin, T
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) : 421 - 429
  • [4] Experience with a once-daily dosing program of aminoglycosides in critically ill patients
    Buijk, SE
    Mouton, JW
    Gyssens, IC
    Verbrugh, HA
    Bruining, HA
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (07) : 936 - 942
  • [5] Once-daily aminoglycoside dosing for critically ill patients with renal insufficiency
    Smith, CJ
    Marini, CP
    Ritter, GS
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (12) : A124 - A124
  • [6] Once-Daily Gentamicin Dosing in Pediatric Patients Without Cystic Fibrosis
    McDade, Erin J.
    Wagner, Jeffrey L.
    Moffett, Brady S.
    Palazzi, Debra L.
    [J]. PHARMACOTHERAPY, 2010, 30 (03): : 248 - 253
  • [7] Experience with a once-daily dosing program of aminoglycosides in critically ill patients
    S. Buijk
    J. Mouton
    I. Gyssens
    H. Verbrugh
    H. Bruining
    [J]. Intensive Care Medicine, 2002, 28 : 936 - 942
  • [8] Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis
    Brink, A. J.
    Richards, G. A.
    Schillack, V.
    Kiem, S.
    Schentag, J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (05) : 432 - 436
  • [9] INSULIN GLARGINE IN CRITICALLY ILL PATIENTS: ONCE-DAILY COMPARED TO TWICE-DAILY DOSING
    Fox, Marlena
    Perry, Melanie
    Liu-DeRyke, Xi
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (01) : 195 - 195
  • [10] Estimation of once-daily amikacin dose in critically ill adults
    Sima, Martin
    Hartinger, Jan
    Cikankova, Tereza
    Slanar, Ondrej
    [J]. JOURNAL OF CHEMOTHERAPY, 2018, 30 (01) : 37 - 43